Skip to main content
Log in

Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The elevated “zero-maze” is a modification of the elevated plus-maze model of anxiety in rats which incorporates both traditional and novel ethological measures in the analysis of drug effects. The novel design comprises an elevated annular platform with two opposite enclosed quadrants and two open, removing any ambiguity in interpretation of time spent on the central square of the traditional design and allowing uninterrupted exploration. Using this model, the reference benzodiazepine anxiolytics, diazepam (0.125–0.5 mg/kg) and chlordiazepoxide (0.5–2.0 mg/kg) significantly increased the percentage of time spent in the open quadrants (% TO) and the frequency of head dips over the edge of the platform (HDIPS), and reduced the frequency of stretched attend postures (SAP) from the closed to open quadrants. In contrast, the anxiogenic drugm-chlorophenyl-piperazine (mCPP; 0.25–1.0 mg/kg) induced the opposite effects, decreasing %TO and HDIPS, and increasing SAP. The 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; 0.001–0.1 mg/kg) had no effects on either %TO or HDIPS, but did decrease SAP at 0.01 mg/kg although not at higher or lower doses. Similarly, the 5-HT3 receptor antagonist, ondansetron (0.0001–1.0 mg/kg) decreased SAP and increased %TO at 0.01 mg/kg, but not at other doses. The present data suggest that a combination of the novel “zero-maze” design and a detailed ethological analysis provides a sensitive model for the detection of anxiolytic/anxiogenic drug action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baldwin HA, File SE (1988) Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull. 20: 603–606

    Google Scholar 

  • Barnett SA (1966) The rat: a study in behavior. Aldine, Chicago

    Google Scholar 

  • Barrett JE, Glesson S (1991) Anxiolytic effects of 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: conflict and drug discrimination studies. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines — their comparative behavioural pharmacology. Wiley, Chichester, pp 59–105

    Google Scholar 

  • Benjamin D, Lal H, Meyerson LR (1990) The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci 47: 195–203

    Google Scholar 

  • Blanchard DC, Blanchard RJ, Tom P, Rodgers RJ (1990) Diazepam changes risk assessment in an anxiety/defense test battery. Psychopharmacology 101: 511–518

    Google Scholar 

  • Blanchard DC, Weatherspoon A, Shepherd JK, Rodgers RJ (1991) “Paradoxical” effects of morphine on antipredator defense reactions in wild and laboratory (R. norvegicus) rats. Pharmacol Biochem Behav 40: 819–828

    Google Scholar 

  • Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94: 397–412

    Google Scholar 

  • Cole JC, Rodgers RJ (1994) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol (in press)

  • Costall B, Naylor, RJ (1991) Anxiolytic effects of 5-HT3 antagonists in animals. In: Rodgers RJ, SJ Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines — their comparative behavioural pharmacology. Wiley, Chichester, pp 133–157

    Google Scholar 

  • Costall B, Kelly ME, Tomkins DM, Tyers MB (1989) Profile of action of diazepam and 5-HT3 receptor antagonists in the elevated X-maze. J Psychopharmacol 3: 10P

  • Cox CP (1987) A handbook of introductory statistical methods. Wiley, New York

    Google Scholar 

  • Critchley MAE, Handley SL (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93: 502–506

    Google Scholar 

  • Critchley MAE, Njung'e K, Handley SL (1992) Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology 106: 484–490

    Google Scholar 

  • Dourish CT (1987) Brain 5-HT1A receptors and anxiety. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors. Ellis Horwood, Chichester, pp 261–277

    Google Scholar 

  • Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus-maze. Eur J Pharmacol 169: 1–10

    Google Scholar 

  • Falter U, Gower AJ, Gobert J (1992) Resistance of baseline activity in the elevated plus-maze to exogenous influences. Behav Pharmacol 3: 123–128

    Google Scholar 

  • File SE (1991) The biological basis of anxiety. In: Meltzer HY, Nerozzi D (eds) Current practices and future developments in the pharmacotherapy of mental disorders. Excerpta Medica, Amsterdam, pp 159–166

    Google Scholar 

  • File SE, Johnston AJ (1989) Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99: 248–251

    Google Scholar 

  • Grant EC, Mackintosh JH (1963) A comparison of the social postures of some common laboratory rodents. Behaviour 21: 246–259

    Google Scholar 

  • Griebel G, Misslin R, Pawlowski M, Vogel E (1991)m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport 2: 627–629

    Google Scholar 

  • Grossen NE, Kelley MJ (1973) Species-specific behavior and acquisition of avoidance behavior in rats. J Comp Physiol Psychol 81: 307–310

    Google Scholar 

  • Handley SL (1991) Serotonin in animal models of anxiety: the importance of stimulus and response. In: Cowen P, Idzikowski C (eds) Serotonin, sleep and mental disorder. Wrightson Biomedical Publications, Petersfield, pp 89–115

    Google Scholar 

  • Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of “fear”-motivated behaviour. Naunyn Schmiedeberg's. Arch Pharmacol 327: 1–5

    Google Scholar 

  • Handley SL, McBlane JW (1993) 5HT drugs in animal models of anxiety. Psychopharmacology 112: 13–20

    Google Scholar 

  • Hoyer D (1988) Functional correlates of serotonin 5HT1 recognition sites. J Recept Res 8: 59–81

    Google Scholar 

  • Johnston A, File SE (1988) Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiatry Res 25: 81–90

    Google Scholar 

  • Kaesermann HP (1986) Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology 89: 31–37

    Google Scholar 

  • Kaesermann HP, Dixon AK (1986) Further validation of the stretched attend posture test, a simple behavioral conflict test in mice. Psychopharmacology 89: S19

  • Kahn RS, Wetzler S (1991)m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30: 1139–1166

    Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94: 137–147

    Google Scholar 

  • Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164: 445–454

    Google Scholar 

  • Klint T (1991) Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats. Behav Pharmacol 2: 481–489

    Google Scholar 

  • Lee C, Rodgers RJ (1990) Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology 102: 507–513

    Google Scholar 

  • Lee C, Rodgers RJ (1991) Effects of benzodiazepine antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice. Neuropharmacology 30: 1263–1267

    Google Scholar 

  • Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92: 180–185

    Google Scholar 

  • Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90: 151–153

    Google Scholar 

  • Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48: 254–260

    Google Scholar 

  • Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99: 48–53

    Google Scholar 

  • Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR (1990) Characterisation of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety; comparison with buspirone 8-OH-DPAT and diazepam. Br J Pharmacol 99: 343–349

    Google Scholar 

  • Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525–529

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open closed arm entires in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149–167

    Google Scholar 

  • Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39: 917–928

    Google Scholar 

  • Pollard GT, Howard JL (1988) Effects of chlordiazepoxide, pentobarbital, buspirone, chlorpromazine, and morphine in the stretched attend posture (SAP) test. Psychopharmacology 94: 433–444

    Google Scholar 

  • Rago L, Kiivet, R-A, Harro, J, Pold M (1988) Behavioural differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn-Schmiedberg's Arch Pharmacol 337: 675–678

    Google Scholar 

  • Rodgers RJ (1991) A step in the right direction: comment on “5-HT and mechanisms of defence”. J Psychopharmacol 5: 316–319

    Google Scholar 

  • Rodgers RJ, Cole JC, Cobain MR Daly P, Doran PJ, Eells JR, Wallis P (1992a) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS12066B, TFMPP and mCPP. Behav Pharmacol 3: 621–634

    Google Scholar 

  • Rodgers RJ, Lee C, Shepherd JK (1992b) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106: 102–110

    Google Scholar 

  • Shepherd JK (1992) Preliminary evaluation of an elevated “zeromaze” as a model of anxiety in laboratory rats. J Psychopharmacol 6 [A56]: 223

    Google Scholar 

  • Shepherd JK, Flores T, Rodgers RJ, Blanchard RJ (1992) The anxiety/defense test battery: influence of gender and ritanserin treatment on antipredator defensive behavior. Physiol Behav 51: 277–285

    Google Scholar 

  • Shepherd JK, Grewal SS, Fletcher, Bill D, Dourish CT (1993) Pharmacological evaluation of the elevated “zero-maze” as a model of anxiety in rats. Br J Pharmacol 110: 13P

  • Soderpalm S, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32: 259–265

    Google Scholar 

  • Suzuki T, Inayama M, Misawa M (1990) The effect of diazepam on exploratory behavior and its strain differences in inbred rats. Jpn J Psychopharmacol 10: 307–314

    Google Scholar 

  • Tomkins DM, Costall B, Kelly ME (1990) Release of suppressed behaviour of rats on the elevated X-maze by 5-HT3 antagonists injected into the basolateral amygdala. J Psychopharmacol 4: 262

    Google Scholar 

  • Treit D, (1991) Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines — their comparative behavioural pharmacology. Wiley, Chichester, pp 107–131

    Google Scholar 

  • Treit D, Fundytus M (1988) Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31: 958–962

    Google Scholar 

  • Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44: 463–469

    Google Scholar 

  • Upton N, Blackburn TP (1991) Anxiolytic-like activity of the selective 5-HT3 receptor antagonist, BRL 46470A, in the rat elevated X-maze. Br J Pharmacol 102: 253P

  • Vasar E, Peuranen E, Oopok T, Harro J, Mannisto PT (1993) Ondansetron, an antagonist of 5-HT3 receptors, antagonises the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Psychopharmacology 110: 213–218

    Google Scholar 

  • Wilkinson LO, Dourish CT (1991) Serotonin and animal behaviour. In: Peroutka SJ (ed) Serotonin receptor subtypes: basic and clinical aspects. Alan R. Liss, New York, pp 149–212

    Google Scholar 

  • Wright IK, Heaton M, Upton N, Marsden CA (1992) Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology 107: 405–414

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shepherd, J.K., Grewal, S.S., Fletcher, A. et al. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology 116, 56–64 (1994). https://doi.org/10.1007/BF02244871

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244871

Key words

Navigation